Neither the agency’s requirement nor yesterday’s ruling has deterred Musk from posting inflammatory tweets on other matters, including his comments yesterday likening George Soros to Magneto, the longtime comic-book villain (who is actually less of a villain these days, but we digress).
Mr. Musk is likely to have an easier time today at Tesla’s annual shareholder meeting: Just one shareholder proposal, on succession planning, is up for a vote. But investors have protested the decision to push up the event by three months, saying it gave them less time to file any dissident shareholder proposals.
Mr. Musk joined other business leaders in France yesterday for a business investment summit. The country’s president, Emmanuel Macron, later tweeted that the two had discussed the electric vehicle market, the energy sector and digital regulation.
Coinbase’s chief wins backing for his longevity bet
Brian Armstrong co-founded Coinbase as a way of disrupting traditional finance systems by making it easier to trade cryptocurrencies. But he has also been busy helping create NewLimit, a start-up focused on breaking past traditional limits of human longevity.
That company is now taking a big step toward advancing its goals: It has raised $40 million in Series A financing, DealBook is first to report, to help fund its research.
NewLimit is looking at reprogramming cells to be young again. By essentially reversing aging through a combination of genetic manipulation and machine learning, the hope goes, scientists would be able to eliminate the underlying causes of many major diseases. “If it works, it will change the arc of humanity,” Mr. Armstrong told DealBook.
Mr. Armstrong, who with the venture capitalist Blake Byers founded NewLimit in 2021 with $100 million of their own money, is the latest tech mogul to be fascinated by longevity. Peter Thiel, OpenAI’s Sam Altman and Oracle’s Larry Ellison are among those who have poured millions into companies researching it.